New personalized vaccine shows promise against tough cancers
NCT ID NCT05741242
First seen Jan 16, 2026 · Last updated May 12, 2026 · Updated 12 times
Summary
This study tests a custom-made vaccine designed to train the immune system to attack a person's specific cancer. It is for 136 adults with solid tumors that have not spread or have spread to other parts of the body. The vaccine is made from unique markers on each patient's tumor, aiming to slow or stop cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anna Gattani MD PC
New York, New York, 10028, United States
-
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, 33140, United States
-
Precision NextGen Oncology & Research Center
Beverly Hills, California, 90212, United States
-
Quest Clinical Research
San Francisco, California, 94115, United States
-
St. Louis Cancer Care
Bridgeton, Missouri, 63044, United States
Conditions
Explore the condition pages connected to this study.